Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes.
暂无分享,去创建一个
D. Neuberg | B. Ebert | R. Bejar | O. Abdel-Wahab | R. Levine | H. Kantarjian | G. Garcia-Manero | K. Stevenson | D. Steensma | A. Raza | B. Caughey | N. Galili | R. Levine